Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic b...
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis
About this item
Full title
Author / Creator
Publisher
Germany: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
We evaluated the diagnostic value of anti-cyclic citrullinated peptide 2 (anti-CCP2) antibodies and other potential diagnostic biomarkers (IgM rheumatoid factor, anti-agalactosyl IgG antibodies, matrix metalloproteinase 3, C-reactive protein) for predicting early development of rheumatoid arthritis (RA). Patients were defined as having recent-onset...
Alternative Titles
Full title
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68273089
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68273089
Other Identifiers
ISSN
0770-3198
E-ISSN
1434-9949
DOI
10.1007/s10067-007-0558-5
